Abstract:Background: The aim of this study is to explore the pathogenic bacteria type, distribution, drug resistance and influencing factors of nosocomial pulmonary infection in patients with lung cancer during chemotherapy. Methods: This study retrospectively analyzed the clinical data of 411 patients with lung cancer who were hospitalized in the First Affiliated Hospital of Zhejiang University Medical College from January 2017 to December 2018, and counted the incidence of nosocomial lung infection, pathogens, drug resistance and influencing factors. Results: There were 184 cases of nosocomial pulmonary infection in 411 lung cancer patients during chemotherapy, the infection rate was 44.77%. The isolated pathogens included Gram-negative bacteria, Gram-positive bacteria, viruses, fungi and tuberculosis, among which Gram-negative bacteria accounted for 37.25%, followed by virus infection, accounting for 15.69%. Pseudomonas aeruginosa and Klebsiella pneumoniae are the main Gram-negative bacteria, Staphylococcus aureus and Streptococcus pneumoniae are the common gram-positive bacteria, influenza B virus is the main virus, Candida and Aspergillus are the most common fungi. The resistance rate of Pseudomonas aeruginosa to imipenem was 26.67%, while that of Klebsiella pneumoniae to imipenem was 12.50%, and that of the main Gram-positive bacteria to vancomycin was 0.00%. Hypoproteinemia, long chemotherapy cycle, high-intensity chemotherapy, chronic obstructive pulmonary disease and basic bronchiectasis were the high risk factors of lung cancer patients with nosocomial pulmonary infection during chemotherapy (P<0.05). Conclusions: During the chemotherapy of lung cancer patients with nosocomial pulmonary infection, the distribution and drug resistance of pathogenic bacteria have certain characteristics. Clinicians should strengthen the detection of pathogenic bacteria and their drug resistance. On the basis of symptomatic treatment, to achieve the purpose of ensuring the treatment effect and prolonging the survival period of patients, preventive measures should be taken for high-risk patients to reduce the chemotherapy cycle and intensity as much as possible to reduce the incidence of infection life.

Clinical Analysis of 34 Cases of Lung Cancer Complicated with Hospital Acquired Pneumonia

Analysis of Common Microorganisms and Antibiotic Resistance of Nosocomial Bacterial Pneumonia in 179 Patients with Lung Cancer

The Clinical Feature and Countermeasures of Hospital-Acquired Pneumonia in Non-Surgical Treatment Elderly Inpatients with Lung Cancer

Distribution of Pathogens in Patients with Malignant Tumor Combined Hospital-Acquired Pneumonia and Analysis of Drug Resistance

Analysis of drug-sensibility and pathogen variance of lower respiratory tract infection accompanying lung cancer

Pathogenic Bacteria of Nosocomial Infection and Their Drug Resistance in Patients with Lung Cancer in Respiratory Intensive Care Unit

ANALYSIS OF PATHOGENIC BACTERIA AND DRUG RESISTANCE OF RESPIRATORY INFECTION ON THE INTERMEDIATE-ADVANCED STAGE LUNG CANCER PATIENTS

Commonly Encountered Pathogens and Their Drug Sensitivity: Analysis of 233 Patients with Lung Infection

Research on etiological feature of hospital infection with lung cancer chemotherapy patients

Pathogens causing nosocomial infections in lung cancer patients treated with chemother-apy and drug susceptibility

Analysis of Classification and Antibiotics Susceptibility of Pathogenic Bacteria in Hospital Acquired Lower Respiratory Tract Infection in Patients with Tumour

Clinical Distribution and Drug Resistance of 4 Non-Fermenting Bacteria of Lower Respiratory Tract Infection

Characterization of Phenotypic and Genotypic Traits of Klebsiella Pneumoniae from Lung Cancer Patients with Respiratory Infection

Clinical Analysis of 38 Cases of Ventilator-Associated Pneumonia

[Characteristics and Influencing Factors of Pathogenic Bacteria in Lung Cancer Chemotherapy Combined with Nosocomial Pulmonary Infection]

Analysis of pathogen distribution and risk factors causing lower respiratory tract infections on chemotherapy patients with lung cancer

Gram-negative bacteria for pulmonary infections in chronic obstructive pulmonary disease and drug resistance analysis

Anaysis of Pathogen and Antibiotic Sensitivity of 52 Cases with Severe Community Acquired Pneumonia

Analysis of distribution and resistance of 353 strains Pseudomonas aeruginosa in clinical infection

Pathogen and Drug-Resistance Analysis of Lower-Respiratory-tract Bacterial Infection in Chronic Obstructive Pulmonary Disease

Analysis on 96 Infected Cases of Streptococcus Pneumoniae